1. Replimune Group faces a securities class action lawsuit. 2. The lawsuit involves alleged fraud impacting investor losses. 3. Claims include overstatement of trial prospects, particularly IGNYTE. 4. Affected period for claims is November 2024 to July 2025. 5. Investors have until September 22, 2025, to act.
Historical evidence shows that class action suits often depress stock prices. For instance, companies like Tesla saw significant downturns during similar lawsuits.
The lawsuit directly questions the integrity of Replimune’s operations and investor trust, significantly affecting potential stock performance.
Market reactions to legal issues are usually immediate, impacting stock prices quickly. The specified deadline by plaintiffs adds urgency to the sentiment.
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ:REPL) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Replimune Group, Inc. investors who were adversely affected by alleged securities fraud between November 22, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=162040&wire=4
REPL investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants recklessly overstated the IGNYTE trial's prospects, given material issues that defendants knew or should have known of, which resulted in the FDA deeming the IGNYTE trial inadequate and not well-controlled; and (2) as a result, defendants' statements about Replimune's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
WHAT'S NEXT? If you suffered a loss in Replimune Group, Inc. during the relevant time frame, you have until September 22, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/class-action-filed-against-replimune-group-inc-repl---september-22-2025-deadline-to-join--contact-levi--korsinsky-302532934.html
SOURCE Levi & Korsinsky, LLP